Novo Nordisk Confirms Russia View With Production Investment

BMI View: BMI expects a wave of foreign direct investment (FDI) in Russia from Big Pharma during 2010-2011 as companies seek to protect their market share from import substitution directives. This view has been supported by a number of large investment announcements during H209. [1][2][3][4] Here we explore the latest multinational to announce manufacturing investment plans: Novo

To read the full article, please choose one of the following options: